GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+25mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated bilayered tablet contains:
Telmisartan IP………………………………………40mg
Cilnidipine IP…………………………………………10mg
Metoprolol succinate IP (47.5mg)
Equivalent to Metoprolol tartrate………..50mg
( as extended release)
Colour: Sunset Yellow Lake
B) Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+25mg)
Each film coated bilayered tablet contains:
Telmisartan IP………………………………………40mg
Cilnidipine IP…………………………………………10mg
Metoprolol succinate IP (23.75mg)
Equivalent to Metoprolol tartrate………..25mg
( as extended release)
Colour: Ponceau-4R Lake and Titanium Dioxide IP
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
Moisture sensitive tablets- do not remove from strip until immediately before administration.
WARNING: WHEN PREGNANCY IS DETECTED, TELMISARTAN SHOULD BE DISCONTINUED AS SOON AS POSSIBLE AS IT CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS WHEN USED DURING SECOND AND THIRD TRIMESTERS OF PREGNANCY.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.
Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+25mg) Technical Specification:
| Product Name: | Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets |
| Brand Name: | Generic |
| Strength: | (40mg+10mg+50mg), (40mg+10mg+25mg) |
| Dosage Form: | Tablets (Film coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10 Blister strips of 10 Tablets Each |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antihypertensive |
| Indication: | Telmisartan + Cilnidipine + Metoprolol Succinate belongs to the group of anti-hypertensive medicines used to treat high blood pressure (hypertension). CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN helps lower the blood pressure, thereby reducing the chances of heart problems such as heart attack and stroke. |
| Storage: | Store at temperature not exceeding 30℃. Store in cool, dry & dark place. Protect from Light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+25mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+25mg)
Each film coated Bilayered tablet contains:
Telmisartan IP………………………………40mg
Cilnidipine IP………………………………10mg
Metoprolol succinate IP (23.75mg)
Equivalent to Metoprolol tartrate………..25mg
( as extended release)
Colour: Ponceau-4R Lake and Titanium Dioxide IP
THERAPEUTIC INDICATIONS:
Telmisartan + Cilnidipine + Metoprolol Succinate belongs to the group of anti-hypertensive medicines used to treat high blood pressure (hypertension). CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN helps lower the blood pressure, thereby reducing the chances of heart problems such as heart attack and stroke.
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
Moisture sensitive tablets– do not remove from strip until immediately before administration.
WARNING: WHEN PREGNANCY IS DETECTED, TELMISARTAN SHOULD BE DISCONTINUED AS SOON AS POSSIBLE AS IT CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS WHEN USED DURING SECOND AND THIRD TRIMESTERS OF PREGNANCY.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.
Introduction to Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+25mg)
Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+25mg) form a comprehensive fixed-dose combination (FDC) used primarily to manage hypertension (high blood pressure). This combination therapy is vital in controlling blood pressure levels effectively, thereby reducing the risk of stroke, heart attack, and other cardiovascular complications.
What Are Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets?
This medication combines three active pharmaceutical ingredients:
- Telmisartan (40mg): An angiotensin II receptor blocker (ARB) that relaxes blood vessels, making it easier for the heart to pump blood.
- Cilnidipine (10mg): A calcium channel blocker that dilates blood vessels and reduces blood pressure.
- Metoprolol Succinate (ER) (25mg): A beta-blocker that decreases heart rate and cardiac output, aiding in blood pressure control.
This combination provides a synergistic effect, making it highly effective for patients with resistant hypertension or those requiring combination therapy for optimal blood pressure management.
Global Demand and Market Insights
The rising prevalence of hypertension globally, especially in urban areas of Asia, Africa, and Latin America, has led to an increased demand for effective antihypertensive medications. India, as a major pharmaceutical manufacturing hub, supplies high-quality Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets to over 50 countries. The demand for affordable, reliable, and WHO-GMP-certified antihypertensive medicines makes India a key exporter in this segment.
Why Is This Combination So Popular?
- Enhanced efficacy in controlling blood pressure
- Reduces the risk of cardiovascular events
- Suitable for resistant hypertension
- Once-daily dosing improves patient compliance
This potent combination is increasingly prescribed worldwide, creating a strong market for manufacturers like Taj Pharma.
Why Taj Pharma Is the Most Trusted Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets Manufacturer & Exporter in India
1. Cutting-Edge Manufacturing Facilities
Taj Pharma’s manufacturing units based in Vapi, Gujarat, are equipped with the latest technology conforming to WHO-GMP standards. They ensure the production of high-quality Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets that meet international quality benchmarks.
2. Competitive Pricing & Strict Quality Control
Taj Pharma offers affordable prices without compromising quality. Their rigorous quality control processes, including stability testing and consistency checks, ensure that every batch meets the highest standards.
3. Extensive Regulatory Support & Documentation
The company provides comprehensive regulatory documentation, including Certificates of Analysis (COA), GMP certificates, export licenses, and CTD dossiers. This simplifies product registration and approval in target markets, expediting market entry.
4. Global Reach & Robust Supply Chain
Taj Pharma exports to over 20 countries worldwide, supported by a resilient supply chain network. Their logistics team manages customs documentation, transportation, and timely delivery, fostering long-term partnerships.
5. Industry Reputation & Customer Satisfaction
As one of India’s top manufacturer, exporter, and supplier of Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets, Taj Pharma has earned trust for their product quality, transparency, and reliable delivery. Their commitment to excellence makes them the preferred partner for global clients.
In-Depth Details for Importers, Exporters & Buyers
Regulatory Documentation & Certifications
Taj Pharma provides all necessary regulatory documents required for international markets, including WHO-GMP, EU-GMP, COPP, and CTD dossiers. These certifications facilitate seamless registration, approval, and import processes.
Custom Packaging & Labeling
Custom packaging options are available to meet regional regulatory standards. Labels can be translated into local languages, and packaging formats include bottles, blister packs, and cartons designed to preserve product integrity during transit.
Shelf-Life, Storage, and Dosage Form
The shelf-life of Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets is typically 2-3 years when stored in a cool, dry place away from light and moisture. The tablets should be stored at room temperature, protected from heat and humidity.
Target Countries & Export Markets
Taj Pharma’s export destinations include North America, Europe, Africa, the Middle East, Southeast Asia, and more. Their adherence to international regulatory standards ensures smooth market entry and compliance.
Why Partner with Taj Pharma? The Most Trusted Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets Manufacturer in India
1. Advanced Manufacturing Infrastructure
Taj Pharma’s manufacturing units incorporate the latest technology, ensuring consistent quality and safety of Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets.
2. Competitive Pricing & Quality Assurance
Their streamlined processes enable them to offer competitive prices to global buyers, making high-quality medicines affordable without sacrificing standards.
3. Extensive Global Supply Chain
Their robust logistics network ensures timely delivery across continents, supported by proper documentation and customs clearance support.
4. Certifications & Regulatory Compliance
Taj Pharma’s products are certified with WHO-GMP, EU-GMP, and ISO standards, simplifying regulatory approval processes in various countries.
Technical Product Specification Table
| Parameter | Specification |
|---|---|
| Active Ingredients | Telmisartan 40mg, Cilnidipine 10mg, Metoprolol Succinate 25mg |
| Dosage Form | Extended-release tablets |
| Appearance | White, round, film-coated tablets |
| Shelf Life | 2-3 years |
| Storage Conditions | Store in a cool, dry place, protected from light |
| Certifications | WHO-GMP, EU-GMP, COPP, ISO-certified |
Call to Action:
Are you looking for a reliable Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets manufacturer and supplier in India? Taj Pharma offers premium-quality, WHO-GMP-certified medicines with flexible packaging options. Reach out now for bulk orders, distributor partnerships, or export inquiries.
Email: info@tajpharma.com
Phone: +9122-2634 1274
Website: www.tajpharma.com
Top 10 FAQs
1. What conditions are these tablets used to treat?
They are used to manage high blood pressure (hypertension), reducing the risk of stroke, heart attack, and other cardiovascular events.
2. How should I take these tablets?
Take one tablet daily at the same time each day, preferably with or without food, as prescribed by your doctor.
3. What are common side effects?
Common side effects include dizziness, headache, nausea, swelling in ankles, flushing, and increased potassium levels. Serious side effects are rare but should be reported immediately.
4. Can I stop taking these tablets suddenly?
No, consult your doctor before discontinuing. Abrupt stopping can lead to rebound hypertension.
5. Are there any precautions?
Inform your healthcare provider about all medical conditions and medications to avoid adverse interactions.
6. Can I consume alcohol while on these tablets?
It is advisable to avoid alcohol, as it may increase side effects like dizziness and low blood pressure.
7. How long does it take to see the effects?
Blood pressure can start to decrease within a few hours, but full therapeutic effects may take a few days to weeks.
8. Can pregnant women take these tablets?
Pregnancy requires medical supervision; consult your doctor before use.
9. How should I store these tablets?
Store in a cool, dry place, protected from light and moisture, out of children’s reach.
10. What should I do if I miss a dose?
Take it as soon as remembered. If close to the next dose, skip the missed one and continue your regular schedule.






